Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-12-28
1980-12-23
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 260112B, G01N 3316, A61K 4300
Patent
active
042410444
ABSTRACT:
This application discloses a method for diagnosing cancer by employing any of various immunochemical procedures to detect elevated levels of anti-(blood group T antigen) antibodies in a biological sample.
REFERENCES:
patent: 3663684 (1972-05-01), Freedman et al.
patent: 3697638 (1972-10-01), Hansen
patent: 3823126 (1974-07-01), Bjorklund
patent: 3867363 (1975-02-01), Hansen
patent: 3956258 (1976-05-01), Hansen
patent: 3960827 (1976-06-01), Bjorklund
patent: 4132767 (1979-01-01), Tohmatsu et al.
patent: 4152410 (1979-05-01), Ishii
patent: 4160817 (1979-07-01), Bucovaz et al.
Abbott Laboratories
Nucker Christine M.
Padgett Benjamin R.
Willmann Neal O.
LandOfFree
Method of diagnosing cancer by detecting elevated anti-T antibod does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of diagnosing cancer by detecting elevated anti-T antibod, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of diagnosing cancer by detecting elevated anti-T antibod will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2242448